Myocardial infarction: recent accomplishments, current questions.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000209:etiology; D001282:Atrial Flutter / Q000209:etiology; D003325:Coronary Care Units; D004077:Digoxin / Q000627:therapeutic use; D006327:Heart Block / Q000209:etiology; D006801:Humans; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D010042:Ouabain / Q000627:therapeutic use; D010138:Pacemaker, Artificial
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D010042:Ouabain; D004077:Digoxin